Cargando…
Daptomycin for the treatment of major gram-positive infections after cardiac surgery
BACKGROUND: Infection is a main cause of morbidity and mortality after heart surgery, with multi-resistant pathogens increasingly representing a challenge. Daptomycin provides bactericidal activity against gram-positive organisms that are resistant to standard treatment including vancomycin. METHODS...
Autores principales: | Kornberger, A., Luchting, B., Kur, F., Weis, M., Weis, F., Stock, U. A., Beiras-Fernandez, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972954/ https://www.ncbi.nlm.nih.gov/pubmed/27488025 http://dx.doi.org/10.1186/s13019-016-0519-7 |
Ejemplares similares
-
Daptomycin as supportive treatment option in patients developing mediastinitis after open cardiac surgery
por: Weis, Florian, et al.
Publicado: (2012) -
Daptomycin: a novel lipopeptide antibiotic against Gram-positive pathogens
por: Beiras-Fernandez, Andres, et al.
Publicado: (2010) -
Levosimendan as rescue therapy in low output syndrome after cardiac surgery: effects and predictors of outcome
por: Beiras-Fernandez, Andres, et al.
Publicado: (2019) -
Treatment of gram-positive deep sternal wound infections in cardiac surgery -experiences with daptomycin-
por: Popov, Aron F, et al.
Publicado: (2011) -
Midterm results after treatment of gram-positive deep sternal wound infections with daptomycin for cardiac surgery patients
por: Ort, Katharina R, et al.
Publicado: (2013)